MAVKX
Price
$15.07
Change
-$0.19 (-1.25%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

MAVKX vs VSIAX

Header iconMAVKX vs VSIAX Comparison
Open Charts MAVKX vs VSIAXBanner chart's image
MoA Small Cap Value Fund
Price$15.07
Change-$0.19 (-1.25%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
MAVKX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MAVKX vs. VSIAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAVKX is a StrongSell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. MAVKX (417M). VSIAX pays higher dividends than MAVKX: VSIAX (2.01) vs MAVKX (1.45). MAVKX was incepted earlier than VSIAX: MAVKX (19 years) vs VSIAX (13 years). MAVKX is a more actively managed with annual turnover of: 22.33 vs. VSIAX (16.00). MAVKX (3000) and VSIAX (3000) have matching initial minimum investment requirements. VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. MAVKX (12.38). VSIAX return over 5 years is better than : 52.83 vs. MAVKX (8.06).
MAVKXVSIAXMAVKX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years13 years-
Gain YTD10.51115.03170%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets417M63B1%
Annual Yield % from dividends1.452.0172%
Returns for 1 year12.3816.2376%
Returns for 3 years-1.6420.67-8%
Returns for 5 years8.0652.8315%
Returns for 10 years8.12105.658%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics